Hello, Welcome to Shine Consultant !
Summit & Event Advisor & Insight Research & Analysis
Guest Information
Lingyu ZHU
Lingyu ZHU
Positions:

CBO

Company:

CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.

Dr. Zhu has more than 20 years of experience in the pharmaceutical industry and worked with both global pharmaceutical companies (Pfizer and JNJ) and Chinese pharmaceutical company. He has done 28 strategic transactions (total value > US$3 billion) including the 2 recent landmark deals in China, the Joint Venture agreement between Amgen and Betta Pharma to commercialize Amgen’s Vectibix (panitumumab) in China for colorectal cancer patients in May 2013, and the US$20 million strategic investment in Xcovery by Betta Pharma and acquired the China right of Ensartinib in October 2014.